The American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) have issued a clinical practice guideline on the management of stimulant use disorder (StUD).
The guideline emphasizes the importance of universal screening for StUD and the use of medications, psychosocial interventions, harm reduction, and contingency management strategies in treatment.
StUD is a significant health crisis due to its long-term health consequences and the increase in overdose deaths involving stimulant drugs over the past decade.